Welcome to our dedicated page for Streamline Health Solutions In news (Ticker: STRM), a resource for investors and traders seeking the latest updates and insights on Streamline Health Solutions In stock.
Streamline Health Solutions, Inc. (STRM) is a healthcare technology company that focuses on helping healthcare organizations address revenue leakage and improve financial performance. Company news releases consistently describe Streamline Health as a provider of integrated solutions, technology-enabled services and analytics that drive compliant revenue and support better financial outcomes across the enterprise.
The STRM news feed highlights developments related to the company’s pre-bill technology solutions, including its eValuator and RevID offerings. Announcements cover new contracts with health systems and hospitals, such as multi-hundred- and thousand-bed organizations in states including Texas, Ohio, Kentucky, Indiana and Florida. These news items often describe how clients are adopting eValuator’s AI-enhanced pre-bill code auditing to improve coding accuracy and avoid denials, or using RevID’s automated charge reconciliation to eliminate charge capture gaps and support accurate billing and cash flow.
Investors and industry observers can also find earnings-related updates in Streamline Health’s news, including quarterly and annual financial results prepared in accordance with GAAP, along with management commentary. The company frequently discusses metrics such as SaaS revenue, Booked SaaS Annual Contract Value (ACV), and Adjusted EBITDA, providing insight into the performance of its SaaS-based revenue cycle solutions.
In addition, the news stream documents major corporate events. In 2025, Streamline Health announced a definitive merger agreement under which MDaudit would acquire the company in an all-cash transaction, followed by updates on the transaction process and completion. For users researching STRM, this news page serves as an archive of contract wins, product-related announcements, financial updates, and merger-related communications.
Streamline Health Solutions (NASDAQ: STRM) announced an underwritten public offering of 8,750,000 shares at a price of $1.60 per share, potentially raising $14.0 million in gross proceeds. The offering includes a 30-day option for underwriters to purchase an additional 1,312,500 shares. The expected closing date is March 2, 2021, subject to customary conditions. Proceeds will be allocated for working capital and general corporate purposes.
Streamline Health Solutions (NASDAQ: STRM) has announced plans for an underwritten public offering of its common stock, with proceeds intended for working capital and general corporate purposes. The offering is contingent on market conditions, and the underwriter may purchase an additional 15% of shares to cover over-allotments. A shelf registration statement for the offering was previously filed with the SEC. Craig-Hallum Capital Group is the managing underwriter. The company continues to emphasize its role in providing revenue integrity solutions for healthcare providers.
Streamline Health Solutions (NASDAQ: STRM) reported its financial results for the third quarter and first nine months of fiscal 2020, concluding on October 31, 2020. Total revenues for Q3 were $2.6 million, down from $3.5 million a year earlier, despite a 48% increase in SaaS revenue. For the first nine months, revenues reached $8.4 million, a decrease from $9.2 million in 2019. The company posted a net income of $1.5 million for this period, attributed to discontinued operations. Adjusted EBITDA for Q3 saw a loss of $0.7 million, while improvements in costs were noted post-ECM business sale.
Streamline Health Solutions (NASDAQ: STRM) will announce its third quarter 2020 financial performance on December 8, 2020, after market close. A conference call to discuss results is scheduled for December 9, 2020, at 9:00 AM ET, accessible via webcast or by phone at 877-269-7756. A replay will be available from December 9 to December 16.
Streamline Health Solutions (NASDAQ: STRM) has expanded its partnership with Allscripts Healthcare Solutions (NASDAQ: MDRX) to include eValuator and Clinical Documentation Integrity (CDI) solutions, enhancing their reseller agreement. This initiative aims to help healthcare providers optimize their revenue cycle, addressing issues like coding errors and compliance risks before billing. The expanded relationship, validated by Allscripts' Go To Market committee, positions Streamline Health's technology as a vital resource for improving financial performance in the healthcare sector.
Streamline Health Solutions announced its financial results for the second quarter and first half of fiscal 2020, ending July 31. The company reported total revenues of $2.9 million for Q2, a 16% increase year-over-year. SaaS revenue grew 46% to $254,000. However, the company faced a net loss of ($1.1 million) for Q2, compared to a ($0.6 million) loss in Q2 2019. For the first half, total revenue reached $5.7 million with $2.5 million in net income, greatly influenced by a $4.7 million gain from discontinued operations. Adjusted EBITDA recorded a loss of ($1.0 million) for the first six months.
Streamline Health Solutions (NASDAQ: STRM) has announced a new contract with a major health system in the Mid-Atlantic, set to utilize its eValuator™ Revenue Integrity Program. This cloud-based solution aims to enhance revenue integrity by identifying coding issues before billing, consequently mitigating revenue leakage and compliance risks. The partnership signifies a growing trend in healthcare towards pre-bill technology, aiming to optimize financial performance amidst evolving payment models. CEO Tee Green highlights the significance of supporting quality care delivery through this collaboration.
Streamline Health Solutions (NASDAQ: STRM) announced plans to release its second quarter 2020 financial results on September 9, 2020, after market close. The results will be discussed in a conference call on September 10, 2020, at 9:00 AM ET, accessible via a live webcast or by phone. A replay will be available from September 10, 2020, to September 17, 2020. Streamline Health specializes in revenue integrity solutions for healthcare providers through its eValuator™ program, aiming to enhance revenue compliance and quality of care.
Streamline Health Solutions (NASDAQ: STRM) has secured a contract with a large academic medical center in the Midwest to implement its eValuator™ Revenue Integrity Program. This technology assists in pre- and post-bill coding analysis to enhance revenue integrity for both inpatient and outpatient services. By identifying coding issues before submission, it aims to reduce revenue leakage and compliance risks. The contract reflects a growing trend among healthcare providers to adopt pre-bill technology to improve financial outcomes amid complex payment guidelines.
Streamline Health Solutions (NASDAQ: STRM) announced a contract with an academic teaching hospital in the Mid Atlantic, utilizing its eValuator system for inpatient billing. This cloud-based automated coding technology aims to enhance revenue integrity by identifying coding issues pre-bill, minimizing revenue leakage, and ensuring compliance. Streamline Health's initiative aligns with the growing demand for such solutions in healthcare, emphasizing the need for accurate coding amidst challenging times. CEO Tee Green highlighted the importance of accurate coding for financial performance and quality care delivery.
FAQ
What is the current stock price of Streamline Health Solutions In (STRM)?
What is the market cap of Streamline Health Solutions In (STRM)?
